AstraZeneca seeks U.S. FDA approval for lung cancer treatment
We haven't written up this one. Investing.com has the full story — the link below goes straight to it.
More in Health & Medicine
Orthopaedic surgeons seek multidisciplinary care for musculoskeletal diseases
Orthopaedic surgeons at a conference in Lagos have called for stronger collaboration among healthcare professionals to improve patient outcomes in musculos Read More…
Pharmacists urged to lead HIV prevention, research
Health researchers urge pharmacists in Nigeria to lead HIV prevention, testing, and research, citing their accessibility and expertise to expand services.
Egetis’ Emcitate cleared by FDA for rare X-linked genetic disease
Egetis Therapeutics has secured US approval of its drug for a rare disease that shortens life expectancy to 35 years. The FDA on Monday backed tiratricol for certain patients with monocarboxylate ...
One in eight new cancers are likely caused by infections—there’s an easy way to protect yourself
Many cancers associated with infection are preventable
Ebola in Congo: More than 8,000 Ebola cases in Congo - soon 4,000 dead
The number of confirmed Ebola cases in the Congo continues to rise, as does the number of deaths. However, in one particularly affected region, there is a hopeful development.
Indian Drugmaker Taps Private Credit for Japanese Acquisition
Indian drugmaker Gujarat Themis Biosyn Ltd. has obtained private credit funding to back its purchase of Japanese peer MicroBiopharm Japan Co., highlighting the growing use of such debt for overseas…